Next‐Generation Cancer‐Specific Hybrid Theranostic Nanomaterials: MAGE‐A3 NIR Persistent Luminescence Nanoparticles Conjugated to Afatinib for In Situ Suppression of Lung Adenocarcinoma Growth and Metastasis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Next‐Generation Cancer‐Specific Hybrid Theranostic Nanomaterials: MAGE‐A3 NIR Persistent Luminescence Nanoparticles Conjugated to Afatinib for In Situ Suppression of Lung Adenocarcinoma Growth and Metastasis
Authors
Keywords
-
Journal
Advanced Science
Volume 7, Issue 9, Pages 1903741
Publisher
Wiley
Online
2020-03-14
DOI
10.1002/advs.201903741
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decoupling Theranostics with Rare Earth Doped Nanoparticles
- (2019) Artiom Skripka et al. ADVANCED FUNCTIONAL MATERIALS
- Afatinib-loaded immunoliposomes functionalized with cetuximab: A novel strategy targeting the epidermal growth factor receptor for treatment of non-small-cell lung cancer
- (2019) Xiaoyan Lu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A Multifunctional Biodegradable Nanocomposite for Cancer Theranostics
- (2019) Jianrong Wu et al. Advanced Science
- Large Hollow Cavity Luminous Nanoparticles with Near-Infrared Persistent Luminescence and Tunable Sizes for Tumor Afterglow Imaging and Chemo-/Photodynamic Therapies
- (2018) Jun Wang et al. ACS Nano
- A new near-infrared persistent luminescence nanoparticle as a multifunctional nanoplatform for multimodal imaging and cancer therapy
- (2018) Junpeng Shi et al. BIOMATERIALS
- Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
- (2018) Cecilia Lopez Sambrooks et al. CANCER RESEARCH
- Long-Lived Emissive Probes for Time-Resolved Photoluminescence Bioimaging and Biosensing
- (2018) Kenneth Yin Zhang et al. CHEMICAL REVIEWS
- Enhanced persistent luminescence of LiGa5O8:Cr3+ near-infrared phosphors by codoping Sn4+
- (2018) Weichao Huang et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS
- Imaging multiple microRNAs in living cells using ATP self-powered strand-displacement cascade amplification
- (2018) Xiangdan Meng et al. Chemical Science
- Long-term in vivo biodistribution and toxicity study of functionalized near-infrared persistent luminescence nanoparticles
- (2018) Xia Sun et al. Scientific Reports
- Mitochondria-Targeted Artificial “Nano-RBCs” for Amplified Synergistic Cancer Phototherapy by a Single NIR Irradiation
- (2018) Liang Zhang et al. Advanced Science
- Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?
- (2018) Gonzalo Recondo et al. Nature Reviews Clinical Oncology
- Chromium-Doped Zinc Gallogermanate@Zeolitic Imidazolate Framework-8: A Multifunctional Nanoplatform for Rechargeable In Vivo Persistent Luminescence Imaging and pH-Responsive Drug Release
- (2018) Ying Lv et al. ACS Applied Materials & Interfaces
- Imaging and therapeutic applications of persistent luminescence nanomaterials
- (2018) Jianhua Liu et al. ADVANCED DRUG DELIVERY REVIEWS
- Near-Infrared Afterglow Luminescent Aggregation-Induced Emission Dots with Ultrahigh Tumor-to-Liver Signal Ratio for Promoted Image-Guided Cancer Surgery
- (2018) Xiang Ni et al. NANO LETTERS
- Rational Design of IR820- and Ce6-Based Versatile Micelle for Single NIR Laser-Induced Imaging and Dual-Modal Phototherapy
- (2018) Xu Hu et al. Small
- Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Lung Cancers
- (2018) Michael Offin et al. CLINICAL CANCER RESEARCH
- Silica shell-assisted synthetic route for mono-disperse persistent nanophosphors with enhanced in vivo recharged near-infrared persistent luminescence
- (2017) Rui Zou et al. Nano Research
- Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
- (2017) Sheng-Kai Liang et al. Oncotarget
- LiGa5O8:Cr-based theranostic nanoparticles for imaging-guided X-ray induced photodynamic therapy of deep-seated tumors
- (2017) Hongmin Chen et al. Materials Horizons
- Long term in vivo imaging with Cr3+ doped spinel nanoparticles exhibiting persistent luminescence
- (2016) B. Viana et al. JOURNAL OF LUMINESCENCE
- Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2016) Johan F Vansteenkiste et al. LANCET ONCOLOGY
- Periodic Mesoporous Organosilica Coated Prussian Blue for MR/PA Dual-Modal Imaging-Guided Photothermal-Chemotherapy of Triple Negative Breast Cancer
- (2016) Wei Tian et al. Advanced Science
- Functionalized gold nanoparticles improve afatinib delivery into cancer cells
- (2015) Sílvia Castro Coelho et al. Expert Opinion on Drug Delivery
- An aptamer targeting shared tumor-specific peptide antigen of MAGE-A3 in multiple cancers
- (2015) Chin-Yu Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma WithEGFRMutations
- (2013) Lecia V. Sequist et al. JOURNAL OF CLINICAL ONCOLOGY
- Lung Cancer: Epidemiology, Etiology, and Prevention
- (2011) Charles S. Dela Cruz et al. CLINICS IN CHEST MEDICINE
- Functionalization of SBA-15 Mesoporous Materials using “Thiol–Ene Click” Michael Addition Reaction
- (2011) Sushma Kumari et al. Journal of Physical Chemistry C
- ZnGa_2O_4:Cr^3+: a new red long-lasting phosphor with high brightness
- (2011) Aurélie Bessière et al. OPTICS EXPRESS
- Ga-Doped ZnS Nanowires as Precursors for ZnO/ZnGa2O4 Nanotubes
- (2008) U. K. Gautam et al. ADVANCED MATERIALS
- The Melanoma-Associated Antigen A3 Mediates Fibronectin-Controlled Cancer Progression and Metastasis
- (2008) W. Liu et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More